← Back to Hearings

Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs

Date & Time: April 01, 2025

Location: Rayburn House Office Building, Room 2123

Chamber: House

Health Subcommittee

Status: Scheduled

Congress: 119

Video

Witnesses (5)

Mr. Carl D’Ruiz, MPH

Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America

Biography

Statement

Truth Statement

Mr. Scott Faber

Senior Vice President, Government Affairs

Biography

Statement

Truth Statement

Mr. Kevin Menzel

Member, Board of Directors, Consumer Healthcare Products Association;

Biography

Statement

Truth Statement

Ms. Kim Wezik, MPH

Director of Advocacy

Biography

Statement

Truth Statement

Mr. Douglas Troutman

Interim Co-Chief Executive Officer

Biography

Statement

Truth Statement

Documents

Official Transcripts

Hearing Transcript

Supporting Materials

Hearing Notice

Supporting Document

The Honorable Brett Guthrie

The Honorable Earl L. "Buddy" Carter

The Honorable Frank Pallone

The Honorable Diana DeGette

Documents For the Record

Hearing Memorandum

Additional Information

Created: 2025-10-07 14:52:09

Last Updated: 2025-10-10 19:49:00

View on Congress.gov